Literature DB >> 25603725

Effects of Two Different Exogenous Surfactant Preparations on Serial Peripheral Perfusion Index and Tissue Carbon Monoxide Measurements in Preterm Infants with Severe Respiratory Distress Syndrome.

Demet Terek1, Deniz Gonulal1, Ozge Altun Koroglu1, Mehmet Yalaz2, Mete Akisu1, Nilgun Kultursay1.   

Abstract

BACKGROUND: Administration of an exogenous surfactant may affect both ventilatory and hemodynamic parameters in preterm infants with respiratory distress syndrome (RDS). Peripheral perfusion may be expected to be influenced, and serial perfusion index (PI) values may show this effect. Noninvasive transcutaneous carbon monoxide (TCO) monitoring may show RDS severity, oxidative and inflammatory stress, and response to surfactant treatment.
METHODS: This randomized controlled nonblinded study was performed in 30 preterm infants with RDS, treated with poractant alfa (n = 15) or beractant (n = 15); 18 preterm infants without RDS served as a control group. Oxygenation and hemodynamic parameters were recorded and compared through the first 6 hours of treatment. PI and TCO values were measured prior to (Tp), immediately after (T0), and at 5 minutes (T5), 30 minutes (T30), 60 minutes (T60), and 360 minutes (T360) after the bolus surfactant administration. The mean arterial pressure, oxygenation index, pH, and lactate levels were recorded simultaneously.
RESULTS: Both study groups had lower Tp PI and higher Tp TCO levels than controls. Both surfactant preparations improved the PI, TCO, mean arterial pressure, oxygenation index, pH, and lactate levels at the end point of T360. However, the median Tp PI value of 1.3 first decreased to 0.86 at T0 (P < 0.001), and then it increased to 0.99 at T5 (p < 0.001) and to 1.25 at T30 (p = 0.037). The median Tp TCO value of 3 decreased to 2, 1.5, 0, and 0 at T0, T5, T30, and T60, respectively (p < 0.001). PI more quickly recovered to Tp values (30 minutes vs. 60 minutes) and reached the control group values (30 minutes vs. 360 minutes) with beractant compared to that with poractant alfa. TCO recovered to Tp values in both groups at the same time (5 minutes vs. 5 minutes), but reached the control group values more quickly (5 minutes vs. 30 minutes) with poractant alfa than with beractant.
CONCLUSION: Patients with RDS had poor perfusion, and PI improved with both surfactant preparations only following a short decline in the 1(st) minute. The expected improvement of PI occurred earlier in the beractant subgroup. TCO declined in both groups, showing lung improvement and decreased oxidative/inflammatory stress, and it was normalized earlier with poractant alfa.
Copyright © 2015. Published by Elsevier B.V.

Entities:  

Keywords:  newborn; perfusion index; respiratory distress syndrome; surfactant; transcutaneous carbon monoxide

Mesh:

Substances:

Year:  2014        PMID: 25603725     DOI: 10.1016/j.pedneo.2014.11.004

Source DB:  PubMed          Journal:  Pediatr Neonatol        ISSN: 1875-9572            Impact factor:   2.083


  5 in total

Review 1.  Comparison of animal-derived surfactants for the prevention and treatment of respiratory distress syndrome in preterm infants.

Authors:  Neetu Singh; Henry L Halliday; Timothy P Stevens; Gautham Suresh; Roger Soll; Maria Ximena Rojas-Reyes
Journal:  Cochrane Database Syst Rev       Date:  2015-12-21

2.  Comparison of efficacy and safety of two available natural surfactants in Iran, Curosurf and Survanta in treatment of neonatal respiratory distress syndrome: A randomized clinical trial.

Authors:  Bita Najafian; Hamidreza Karimi-Sari; Mohammad Hossein Khosravi; Niloofar Nikjoo; Sobhan Amin; Majid Shohrati
Journal:  Contemp Clin Trials Commun       Date:  2016-04-13

Review 3.  Beractant and poractant alfa in premature neonates with respiratory distress syndrome: a systematic review of real-world evidence studies and randomized controlled trials.

Authors:  Manuel Sánchez Luna; Peter Bacher; Kristina Unnebrink; Marisol Martinez-Tristani; Cristina Ramos Navarro
Journal:  J Perinatol       Date:  2020-02-12       Impact factor: 2.521

4.  Porcine vs bovine surfactant therapy for preterm neonates with RDS: systematic review with biological plausibility and pragmatic meta-analysis of respiratory outcomes.

Authors:  Ascanio Tridente; Lucia De Martino; Daniele De Luca
Journal:  Respir Res       Date:  2019-02-06

5.  Porcine versus bovine surfactant therapy for RDS in preterm neonates: pragmatic meta-analysis and review of physiopathological plausibility of the effects on extra-pulmonary outcomes.

Authors:  Silvia Foligno; Daniele De Luca
Journal:  Respir Res       Date:  2020-01-07
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.